Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

satavaptan

Known as: Benzamide, N-(1,1-dimethylethyl)-4-((cis-5'-ethoxy-4-(2-(4-morpholinyl)ethoxy)-2'-oxospiro(cyclohexane-1,3'-(3H)indol)-1'(2'H)-yl)sulfonyl)-3-methoxy- 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
OBJECTIVE Satavaptan, a vasopressin V2 receptor antagonist, has been shown to improve the control of ascites in cirrhosis in… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Review
2012
Review
2012
Arginine vasopressin (AVP) is a neuropeptide hormone that plays an important role in circulatory and sodium homeostasis, and… Expand
  • figure 1
  • table I
  • table II
  • table III
  • figure 2
Is this relevant?
2011
2011
AIMS Arginine vasopressin (AVP) V(2) receptor antagonism is a new approach to the management of hyponatraemia in congestive heart… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND & AIMS Cirrhotic patients with recurrent ascites frequently require paracentesis despite diuretic therapy. Vasopressin… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2010
2010
BACKGROUND There is little information on the effects of vaptans in patients with cirrhosis. AIM To investigate the short-term… Expand
Is this relevant?
2009
2009
Despite major therapeutic advances, the incidence of diabetic nephropathy remains worrisome. Classical factors contributing to… Expand
  • figure 1
Is this relevant?
Highly Cited
2008
Highly Cited
2008
UNLABELLED Hyponatremia in cirrhosis is associated with significant morbidity and mortality and complicates ascites management… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Review
2008
Review
2008
Arginine-vasopressin is a hormone that plays an important part in circulatory and water homoeostasis. The three arginine… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2007
Review
2007
BackgroundHyponatremia is among the metabolic disturbances encountered in oncology. Risk factors for hyponatremia include… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
The effects of satavaptan (SR121463B), a novel long-acting orally active vasopressin V(2)-receptor antagonist, were investigated… Expand
Is this relevant?